UF Researchers: Stress Can Hasten Progression Of HIV

August 08, 1997

GAINESVILLE---Stress can accelerate the progression of the early stages of HIV disease, report researchers from the University of Florida and the University of North Carolina at Chapel Hill.

In fact, for every severe stress a patient reported in a six-month period, the risk of early disease progression doubled. And among those tracked for at least two years, higher severe life stress increased the odds of developing HIV disease progression nearly fourfold, researchers wrote in the June issue of the American Journal of Psychiatry.

While other studies have suggested stress and depression can alter the body's ability to fight off illness, few have rigorously examined the role of emotional factors in the onset and course of immune-based diseases such as cancer and AIDS, says Dr. John M. Petitto, associate professor of psychiatry, neuroscience and pharmacology at UF's College of Medicine and the UF Brain Institute.

"This study provides among the first evidence that severe life stress increases the likelihood and severity of early HIV disease progression," Petitto said.

Researchers studied 93 homosexual men, ages 18 to 51, who tested positive for HIV but showed no symptoms of the disease when they entered the trial. They were recruited from rural and urban areas of North Carolina through state health departments, advertisements in gay publications and gay organizations, and word of mouth.

To be eligible for the study, they could have no previous intravenous drug use as a risk factor for HIV, could not drink heavily or use recreational drugs and could not be taking medications affecting the immune system, such as antibiotics.

Participants, who were studied up to 42 months, were asked about more than 100 possible stresses at six-month intervals, including death of a mate, arrest, trouble with a boss, chronic financial difficulties or breakup of a love relationship.

Researchers then assigned a "degree of threat" to the stress; in other words, the unpleasantness and uncertainty most people would experience given the same circumstances. For example, the long-term stress associated with the breakup of a committed relationship was based on the length of time the two were together, whether the patient lived with the person, whether the patient had control over the decision and other extenuating circumstances.

In addition, to eliminate the chance that the stress of worsening disease might have influenced disease progression, researchers excluded disease-related stresses such as the onset of symptoms of AIDS-related complex, job loss due to dementia or a mate leaving because the disease worsened.

The study showed that only severe stress had an influence; levels of stress common to everyday living did not seem to play a role in disease progression, Petitto said.

Because HIV progresses at varying rates among patients, showing that stress can influence the course of illness could have implications for treatment, he said.

"If we are able to identify factors that account for this disparity, that information could someday have implications for the treatment of HIV-infected individuals," Petitto said. "Further studies are required to shed light on the potential immune or other biological factors that may underlie the relationship between stress and disease progression."


University of Florida

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.